recent articles

From Diagnostics World: By Deborah Borfitz  March 7, 2024 | Biomedical engineers have a significant role to play in the development and optimization of liquid biopsies to further precision oncology. Although molecular...

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel...

Indica Labs: Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer. Lung PD-L1 AI: Development and Validation of an Automated PD-L1 Tumor Proportion Scoring Algorithm in Non-Small Cell Lung...

Gestalt Diagnostics: Algorithm for Use on Eight Types of Cancer Trained on Seven Scanner Models SPOKANE, Wash., Sept. 19, 2023 /PRNewswire/ -- Gestalt Diagnostics is proud to announce our latest release – an AI algorithm for use on one of...

Lunit, a firm specializing in cancer diagnostics and therapeutics powered by artificial intelligence (AI), announced the presentation of data from a collaborative study on the use of the Lunit SCOPE IO test to predict immunotherapy treatment...

From Imagene: A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients TEL AVIV, Israel, July 26, 2023 (Newswire.com) - Imagene, an emerging leader in AI-based precision oncology, is pleased...

OR

platinum partners

gold partners

Silver Partners

Media Partners